TABLE 4.

Genotyping and categorization of recurrent infections^a

Patient code	MS marker analysis		SNP barcode analysis		WGS
	Discordant MS (no./total)	Typeb	Discordant SNP (no./total)	Typec	IBS		IBD
					Discordant SNP (%)	Typed	% IBD	Typee
003	0/3	Homologous	1/38	Heterologous
007	0/4	Homologous	2/38	Heterologous	14.3	Heterologous	35.2	Heterologous
008	0/4	Homologous	0/37	Homologous	2.2	Homologous	99.9	Homologous
010			1/38	Heterologous
018	0/2	Homologous
021	4/4	Heterologous
022	0/4	Homologous	0/37	Homologous	6.8	Heterologous	98.1	Homologous
027	0/4	Homologous			2.3	Homologous	99.5	Homologous
028
034	1/4	Heterologous	0/38	Homologous	1.6	Homologous	99.8	Homologous
037					2.0	Homologous	99.7	Homologous
043	0/3	Homologous	1/38	Heterologous	12.6	Heterologous	99.8	Homologous
044	0/3	Homologous
047	1/3	Heterologous	0/22	Homologous	8.0	Heterologous	32.5	Heterologous
048	0/3	Homologous	0/20	Homologous	1.7	Homologous	99.5	Homologous
050	0/3	Homologous
053	0/4	Homologous	0/38	Homologous
054	0/4	Homologous	5/38	Heterologous	2.4	Homologous	100	Homologous

^aAn extended version is provided in Table S4. MS, microsatellites (Pvmsp1F3 + MS4 + MS10 + PvSal1814); IBS, identity by state; IBD, identity by descent; WGS, whole-genome sequencing.

^bRate of homologous infections, 12/15 (80%).

^cRate of homologous infections, 6/11 (55%).

^dRate of homologous infections, 6/10 (60%).

^eRate of homologous infections, 8/10 (80%).